a public good project by the
Synthesis
Company
of California

© 2026

M. Angela Cenci | doi.page

0 works0 citations0 h-index

M. Angela Cenci

Lund University(SE)

Publications by Year

Research Areas

Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Neuroscience and Neuropharmacology Research, Nerve injury and regeneration, Neurotransmitter Receptor Influence on Behavior

Most-Cited Works

→ Loss of bidirectional striatal synaptic plasticity in L-DOPA–induced dyskinesia(2003)812 cited
→ Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease(2002)663 cited
→ L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA(1998)613 cited
→ L‐DOPA‐induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin‐ and glutamic acid decarboxylase mRNA(1998)541 cited
→ Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease(2015)465 cited
→ Animal models of neurological deficits: how relevant is the rat?(2002)449 cited

→ M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia.(2015)

437 cited

→ l-DOPA-Induced Dyskinesia in the Intrastriatal 6-Hydroxydopamine Model of Parkinson's Disease: Relation to Motor and Cellular Parameters of Nigrostriatal Function(2002)425 cited

→ Striatal fosB Expression Is Causally Linked with l-DOPA-Induced Abnormal Involuntary Movements and the Associated Upregulation of Striatal Prodynorphin mRNA in a Rat Model of Parkinson's Disease(1999)347 cited

→ A model of l-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function(2004)326 cited